Transaction #2161 · Form 4 · 0002092127-25-000004
Savara Inc · Stock award · Stock Option (Right to Buy)
Savara Inc · Transacted October 20, 2025 · Filed October 22, 2025
What does this filing report?
An SEC Form 4 filing for Savara Inc records a stock award involving Stock Option (Right to Buy) on October 20, 2025. The reported quantity was 70,000. The filing date is October 22, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Savara Inc
- Company CIK
- 0001160308
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 70,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 70,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 22, 2025, 8:47 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Wasfi Yasmine ↗
Chief Medical Officer
CIK 0002092127
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 70,000
- Conversion / exercise price
- 4.11
- Exercise date
- Not reported
- Expiration date
- October 20, 2035
Filing footnotes & remarks
- F1
- Represents restricted stock units ("RSUs") that vest in full on October 17, 2027, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2
- The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of October 17, 2025, subject to the reporting person's continued service with the Issuer.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.